{"url":"https://lda.senate.gov/api/v1/filings/7e310e77-e25b-4c01-8d2c-4f449cf6634c/","filing_uuid":"7e310e77-e25b-4c01-8d2c-4f449cf6634c","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2025,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/7e310e77-e25b-4c01-8d2c-4f449cf6634c/print/","filing_document_content_type":"text/html","income":null,"expenses":"100000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"David Root","dt_posted":"2025-07-16T14:58:11-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":"United States of America","registrant_address_1":"2900 Ames Crossing Road","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Eagan","registrant_state":"MN","registrant_zip":"55121","registrant":{"id":400339576,"url":"https://lda.senate.gov/api/v1/registrants/400339576/","house_registrant_id":null,"name":"PRIME THERAPEUTICS","description":"Pharmacy Benefit Management","address_1":"2900 Ames Crossing Road","address_2":null,"address_3":null,"address_4":null,"city":"Eagan","state":"MN","state_display":"Minnesota","zip":"55121","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"DAVID ROOT","contact_telephone":"+1 804-834-2626","dt_updated":"2026-07-16T14:49:10.397000-04:00"},"client":{"id":189439,"url":"https://lda.senate.gov/api/v1/clients/189439/","client_id":12,"name":"PRIME THERAPEUTICS","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"MN","state_display":"Minnesota","country":"US","country_display":"United States of America","ppb_state":"MN","ppb_state_display":"Minnesota","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2010-06-16"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"H.R.2214: The DRUG Act, provisions related to PBM compensation. S.891: The Bipartisan Health Care Act, provisions related to PBM regulation. H.R.10445 (118th Congress): Further Consolidating Appropriations and Disaster Relief Supplemental Appropriations Act, Division E, Healthcare, provisions regulating pharmacy benefit managers. H.R.5378 (118th Congress): Lower Cost, More Transparency Act. S.526 Pharmacy Benefit Manger Transparency Act of 2025, provisions related to transparency and pharmacy and PBM compensation. S.1339 PBM Reform Act (118th Congress): provisions related to PBM compensation.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":65234,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":"CAROL","last_name":"CANTOR-WEINBERG","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"S.832: EPIC Act, provisions on eligibility for Medicare drug price negotiation. S.891: The Bipartisan Health Care Act, provisions related to PBM regulation. H.R.10445 (118th Congress): Further Consolidating Appropriations and Disaster Relief Supplemental Appropriations Act, Division E, Healthcare, provisions regulating pharmacy benefit managers. H.R.5378 (118th Congress): Lower Cost, More Transparency Act. H.R.1: The One Big Beautiful Bill (House version), provisions on PBM transparency, audit rights and payments.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":65234,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":"CAROL","last_name":"CANTOR-WEINBERG","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"Tariffs on pharmaceuticals.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":65234,"prefix":null,"prefix_display":null,"first_name":"JULIE","nickname":null,"middle_name":"CAROL","last_name":"CANTOR-WEINBERG","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}